|
|||
| 1 | A bill to be entitled | ||
| 2 | An act relating to the Florida Medicaid program; amending | ||
| 3 | s. 409.9066, F.S.; requiring certain drug manufacturers to | ||
| 4 | disclose average wholesale prices of drugs provided | ||
| 5 | through the program; requiring the Agency for Health Care | ||
| 6 | Administration to publish such information on a website; | ||
| 7 | providing an effective date. | ||
| 8 | |||
| 9 | Be It Enacted by the Legislature of the State of Florida: | ||
| 10 | |||
| 11 | Section 1. Section 409.9066, Florida Statutes, is amended | ||
| 12 | to read: | ||
| 13 | 409.9066 Medicare prescription discount program.-- | ||
| 14 | (1) As a condition of participation in the Florida | ||
| 15 | Medicaid program or the pharmaceutical expense assistance | ||
| 16 | program, a pharmacy must agree to charge any individual who is a | ||
| 17 | Medicare beneficiary and who is a Florida resident showing a | ||
| 18 | Medicare card when he or she presents a prescription, a price no | ||
| 19 | greater than the cost of ingredients equal to the average | ||
| 20 | wholesale price minus 9 percent, and a dispensing fee of $4.50. | ||
| 21 | (2) In lieu of the provisions of subsection (1), and as a | ||
| 22 | condition of participation in the Florida Medicaid program or | ||
| 23 | the pharmaceutical expense assistance program, a pharmacy must | ||
| 24 | agree to: | ||
| 25 | (a) Provide a private voluntary prescription discount | ||
| 26 | program to state residents who are Medicare beneficiaries; or | ||
| 27 | (b) Accept a private voluntary discount prescription | ||
| 28 | program from state residents who are Medicare beneficiaries. | ||
| 29 | |||
| 30 | Discounts under this subsection must be at least as great as | ||
| 31 | discounts under subsection (1). | ||
| 32 | (3) As a condition of participation in the Florida | ||
| 33 | Medicaid program or the pharmaceutical expense assistance | ||
| 34 | program, a drug manufacturer must disclose the average wholesale | ||
| 35 | price of all prescription drugs eligible for sale pursuant to | ||
| 36 | subsection (1). The drug manufacturer shall disclose the average | ||
| 37 | wholesale price by providing such information no later than once | ||
| 38 | every 6 months to the Agency for Health Care Administration, | ||
| 39 | which shall publish the information on a free website available | ||
| 40 | to the public. | ||
| 41 | Section 2. This act shall take effect July 1, 2003. | ||
| 42 | |||